8 AGO 2017 · Today on Burning Issues Dr. Mitch is Joined by ​​Franjo Grotenhermen, MD. Franjo has devoted the last 15 years of his career to the investigation of scientific and policy issues related to the medicinal and recreational use of cannabis and cannabinoids. Dr. Grotenhermen is founder and chairman of the Association for Cannabis as Medicine (ACM) and founder and executive director of the International Association for Cannabis as Medicine (IACM) (www.cannabis-med.org). The ACM was founded in 1997 by physicians, patients and others advocating the medical use of cannabis. Its members are from the German speaking countries. The ACM formed the basis of the International Association for Cannabis as Medicine (IACM), a scientific association, which serves as a global clearinghouse for science-based information on the medicinal uses of cannabis and continues to provide information to other researchers, patients, pharmaceutical firms, policy makers, and the media. He is editor of the IACM-Bulletin, which is published bi-weekly in six languages (English, German, French, Spanish, Dutch and Italian) and editor of the internet journal CANNABINOIDS, published on the website of the IACM. He is a principal of the nova-Institute based near Cologne and author of many articles, books and book chapters on the therapeutic potential, pharmacology and toxicology of the cannabinoids. He is an expert and consultant on these issues for private persons, companies, courts and institutions, including the World Health Organization.

4 AGO 2017 · Today on Burning Issues we talk to David Bearman, M.D. about cannabis treatment for ADD and ADHD. Dr. Bearman is one of the most clinically knowledgeable physicians in the U.S. in the field of medicinal marijuana. He has spent 40 years working in substance and drug abuse treatment and prevention programs. Dr. Bearman was a pioneer in the free and community clinic movement. His career includes public health, administrative medicine, provision of primary care, pain management and cannabinology. His almost 40 year professional experience in the drug abuse treatment and prevention field includes being the Co-Director of the Haight-Ashbury Drug Treatment Program, being a member of Governor Reagan’s Inter Agency Task Force on Drug Abuse, a member of both the Santa Barbara and the San Diego County Drug Abuse Technical Advisor Committees, and a consultant to Hoffman-LaRoche, Santa Barbara County Schools and the National PTA. He has been recognized by the Santa Barbara Medical Society with the Humanitarian Recognition Award.

31 LUG 2017 · Cannabis Case Studies and Clinical Trials as Dr. Mitch Earleywine welcomes Associate Professor Emeritus of Psychiatry at Harvard Medical School Dr. Lester Grinspoon.

29 GIU 2017 · Today on Burning Issues Dr. Mitch is Joined by Julie Holland, M.D. Julie is a psychiatrist specializing in psychopharmacology, with a private practice in New York City. She majored in the Biological Basis of Behavior at the University of Pennsylvania and received her M.D. in 1992 from Temple University School of Medicine. At Mount Sinai Medical Center, she completed a residency program in psychiatry, where she created a research project that treated schizophrenics with a new medication. Together they talk about The evidence-base supporting the likelihood of safety and efficacy of cannabis for ADHD in adults and the need for definitive clinical trials. Also, Possible mechanism of action of THC, CBD etc in ADHD, including any basis in science for current working theory that cannabis provides focus through retrograde inhibition of GABA to create more Dopamine Transporter.

29 GIU 2017 · Dr. Mitch speaks with Dr. Patel about the many questions asked regarding marijuana doctors and the instructions given by doctors on how to safely use and determine the proper dosage of marijuana

29 GIU 2017 · Today on Burning Issues DR. Mich is Joined by Professor Philip Asherson from the Institute of Psychiatry, Psychology & Neuroscience. At King's College London Professor Philip is the head of The ADHD Genetics Group. This group is a research group within the SGDP whose main aim is to identify the genes involved in ADHD and related behavioural traits, and investigate how such genes work together and with environment to influence behaviour.

19 GIU 2017 · Today on Burning Issues Dr. Mich is joined by Erik Altieri the communications director of NORML. They talk about how Medical Cannabis Patients Report Decreased Use Of Opioids, Anti-Anxiety Medicines. This topic is based on Patients with legal access to medical cannabis decreasing their use of opioids, anti-depressants, anti-anxiety drugs, and other medications, according to self-report data published online ahead of print in the Journal of Psychopharmacology. The study's findings are consistent with those of others reporting that patients with legal cannabis access are less likely to use or abuse opioids, as well as various other prescription medications, including anti-anxiety medicines and anti-depressants.

5 GIU 2017 · Dr. Mitch Earleywine speaks with Matthew R. Pearson, Ph.D. a Research Assistant Professor from the Center on Alcoholism, Substance Abuse, and Addictions at the University of New Mexico.

24 APR 2017 · Today on Burning Issues Dr. Mitch is joined by Jordan Page, a cannabis freedom activist and the PR Director for CannaSense. Cannasense is providing legal access to medical cannabis through a framework of existing state and federal laws, to patients in all 50 states. As a medical cannabis collective they use a specific legal strategy, developed over 10 years of research, to provide and ship cannabis medication to patients across the US regardless of individual state mandates. They are in strict compliance with state and federal laws including the Compassionate Use Act, the Affordable Care Act, and Article 4 Section 1 of the US Constitution, among many others. Under the provisions of the CUA and through the vehicle of telemedicine, they connect patients in every state with CA board certified medical doctors who issue them medical cards and recommendations for membership in our collective, thereby making them CA patients.

20 FEB 2017 · Los Angeles is about to presented with Proposition M which will provide the city with the ability to address issues in a comprehensive way. One of the biggest publications in Media The Los Angeles Times has now come out and backed Proposition M. Dr. Mich speaks to Virgil Grant, president and co-founder of Southern California Coalition about his take on this media backing.